Manufacturers looking to employ these solutions should give strong validation data to show their equivalence to pharmacopoeial procedures. As these new systems emerge, the WHO emphasizes the value of a thorough possibility assessment and validation approach. Offering a managed, aseptic setting for that preparation and handling of sensitiv